Thiazole compounds as protein kinase B (PKB) Inhibitors
The invention relates to methods of using thiazole compounds of Formula I and Formula II and compositions thereof for treating diseases mediated by protein kinase B (PKB) such as cancer and other proliferative disorders where the variables have the definitions provided herein.
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | WOHLHIETER, GEORGE E WANG, XIANGHONG HUANG, XIN RIDER, JAMES T LIU, QINGYIAN VISWANADHAN, VELLARKAD N LI, AIWEN LEE, MATTHEW R FOTSCH, CHRISTOPHER H YUAN, CHESTER CHENGUANG ZENG, QINGPING HAH, NIANHE WEILER, KURT E YAO, GUOMIN BOURBEAU, MATTHEW P DOMINGUEZ, CELIA TASKER, ANDREW S ALLEN, JOHN G TADESSE, SEIFU HONG, FANG-TSAO |
| description | The invention relates to methods of using thiazole compounds of Formula I and Formula II and compositions thereof for treating diseases mediated by protein kinase B (PKB) such as cancer and other proliferative disorders where the variables have the definitions provided herein. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ZA200806386B</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ZA200806386B</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ZA200806386B3</originalsourceid><addsrcrecordid>eNrjZDAPychMrMrPSVVIzs8tyC_NSylWSCxWKCjKL0nNzFPIzsxLLE5VcFLQCPB20lTwzMvITMosyS8q5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8VGORgYGFgZmxhZmTsbEqAEAdectCQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Thiazole compounds as protein kinase B (PKB) Inhibitors</title><source>esp@cenet</source><creator>WOHLHIETER, GEORGE E ; WANG, XIANGHONG ; HUANG, XIN ; RIDER, JAMES T ; LIU, QINGYIAN ; VISWANADHAN, VELLARKAD N ; LI, AIWEN ; LEE, MATTHEW R ; FOTSCH, CHRISTOPHER H ; YUAN, CHESTER CHENGUANG ; ZENG, QINGPING ; HAH, NIANHE ; WEILER, KURT E ; YAO, GUOMIN ; BOURBEAU, MATTHEW P ; DOMINGUEZ, CELIA ; TASKER, ANDREW S ; ALLEN, JOHN G ; TADESSE, SEIFU ; HONG, FANG-TSAO</creator><creatorcontrib>WOHLHIETER, GEORGE E ; WANG, XIANGHONG ; HUANG, XIN ; RIDER, JAMES T ; LIU, QINGYIAN ; VISWANADHAN, VELLARKAD N ; LI, AIWEN ; LEE, MATTHEW R ; FOTSCH, CHRISTOPHER H ; YUAN, CHESTER CHENGUANG ; ZENG, QINGPING ; HAH, NIANHE ; WEILER, KURT E ; YAO, GUOMIN ; BOURBEAU, MATTHEW P ; DOMINGUEZ, CELIA ; TASKER, ANDREW S ; ALLEN, JOHN G ; TADESSE, SEIFU ; HONG, FANG-TSAO</creatorcontrib><description>The invention relates to methods of using thiazole compounds of Formula I and Formula II and compositions thereof for treating diseases mediated by protein kinase B (PKB) such as cancer and other proliferative disorders where the variables have the definitions provided herein.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20091125&DB=EPODOC&CC=ZA&NR=200806386B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20091125&DB=EPODOC&CC=ZA&NR=200806386B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WOHLHIETER, GEORGE E</creatorcontrib><creatorcontrib>WANG, XIANGHONG</creatorcontrib><creatorcontrib>HUANG, XIN</creatorcontrib><creatorcontrib>RIDER, JAMES T</creatorcontrib><creatorcontrib>LIU, QINGYIAN</creatorcontrib><creatorcontrib>VISWANADHAN, VELLARKAD N</creatorcontrib><creatorcontrib>LI, AIWEN</creatorcontrib><creatorcontrib>LEE, MATTHEW R</creatorcontrib><creatorcontrib>FOTSCH, CHRISTOPHER H</creatorcontrib><creatorcontrib>YUAN, CHESTER CHENGUANG</creatorcontrib><creatorcontrib>ZENG, QINGPING</creatorcontrib><creatorcontrib>HAH, NIANHE</creatorcontrib><creatorcontrib>WEILER, KURT E</creatorcontrib><creatorcontrib>YAO, GUOMIN</creatorcontrib><creatorcontrib>BOURBEAU, MATTHEW P</creatorcontrib><creatorcontrib>DOMINGUEZ, CELIA</creatorcontrib><creatorcontrib>TASKER, ANDREW S</creatorcontrib><creatorcontrib>ALLEN, JOHN G</creatorcontrib><creatorcontrib>TADESSE, SEIFU</creatorcontrib><creatorcontrib>HONG, FANG-TSAO</creatorcontrib><title>Thiazole compounds as protein kinase B (PKB) Inhibitors</title><description>The invention relates to methods of using thiazole compounds of Formula I and Formula II and compositions thereof for treating diseases mediated by protein kinase B (PKB) such as cancer and other proliferative disorders where the variables have the definitions provided herein.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAPychMrMrPSVVIzs8tyC_NSylWSCxWKCjKL0nNzFPIzsxLLE5VcFLQCPB20lTwzMvITMosyS8q5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8VGORgYGFgZmxhZmTsbEqAEAdectCQ</recordid><startdate>20091125</startdate><enddate>20091125</enddate><creator>WOHLHIETER, GEORGE E</creator><creator>WANG, XIANGHONG</creator><creator>HUANG, XIN</creator><creator>RIDER, JAMES T</creator><creator>LIU, QINGYIAN</creator><creator>VISWANADHAN, VELLARKAD N</creator><creator>LI, AIWEN</creator><creator>LEE, MATTHEW R</creator><creator>FOTSCH, CHRISTOPHER H</creator><creator>YUAN, CHESTER CHENGUANG</creator><creator>ZENG, QINGPING</creator><creator>HAH, NIANHE</creator><creator>WEILER, KURT E</creator><creator>YAO, GUOMIN</creator><creator>BOURBEAU, MATTHEW P</creator><creator>DOMINGUEZ, CELIA</creator><creator>TASKER, ANDREW S</creator><creator>ALLEN, JOHN G</creator><creator>TADESSE, SEIFU</creator><creator>HONG, FANG-TSAO</creator><scope>EVB</scope></search><sort><creationdate>20091125</creationdate><title>Thiazole compounds as protein kinase B (PKB) Inhibitors</title><author>WOHLHIETER, GEORGE E ; WANG, XIANGHONG ; HUANG, XIN ; RIDER, JAMES T ; LIU, QINGYIAN ; VISWANADHAN, VELLARKAD N ; LI, AIWEN ; LEE, MATTHEW R ; FOTSCH, CHRISTOPHER H ; YUAN, CHESTER CHENGUANG ; ZENG, QINGPING ; HAH, NIANHE ; WEILER, KURT E ; YAO, GUOMIN ; BOURBEAU, MATTHEW P ; DOMINGUEZ, CELIA ; TASKER, ANDREW S ; ALLEN, JOHN G ; TADESSE, SEIFU ; HONG, FANG-TSAO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ZA200806386B3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2009</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>WOHLHIETER, GEORGE E</creatorcontrib><creatorcontrib>WANG, XIANGHONG</creatorcontrib><creatorcontrib>HUANG, XIN</creatorcontrib><creatorcontrib>RIDER, JAMES T</creatorcontrib><creatorcontrib>LIU, QINGYIAN</creatorcontrib><creatorcontrib>VISWANADHAN, VELLARKAD N</creatorcontrib><creatorcontrib>LI, AIWEN</creatorcontrib><creatorcontrib>LEE, MATTHEW R</creatorcontrib><creatorcontrib>FOTSCH, CHRISTOPHER H</creatorcontrib><creatorcontrib>YUAN, CHESTER CHENGUANG</creatorcontrib><creatorcontrib>ZENG, QINGPING</creatorcontrib><creatorcontrib>HAH, NIANHE</creatorcontrib><creatorcontrib>WEILER, KURT E</creatorcontrib><creatorcontrib>YAO, GUOMIN</creatorcontrib><creatorcontrib>BOURBEAU, MATTHEW P</creatorcontrib><creatorcontrib>DOMINGUEZ, CELIA</creatorcontrib><creatorcontrib>TASKER, ANDREW S</creatorcontrib><creatorcontrib>ALLEN, JOHN G</creatorcontrib><creatorcontrib>TADESSE, SEIFU</creatorcontrib><creatorcontrib>HONG, FANG-TSAO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WOHLHIETER, GEORGE E</au><au>WANG, XIANGHONG</au><au>HUANG, XIN</au><au>RIDER, JAMES T</au><au>LIU, QINGYIAN</au><au>VISWANADHAN, VELLARKAD N</au><au>LI, AIWEN</au><au>LEE, MATTHEW R</au><au>FOTSCH, CHRISTOPHER H</au><au>YUAN, CHESTER CHENGUANG</au><au>ZENG, QINGPING</au><au>HAH, NIANHE</au><au>WEILER, KURT E</au><au>YAO, GUOMIN</au><au>BOURBEAU, MATTHEW P</au><au>DOMINGUEZ, CELIA</au><au>TASKER, ANDREW S</au><au>ALLEN, JOHN G</au><au>TADESSE, SEIFU</au><au>HONG, FANG-TSAO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Thiazole compounds as protein kinase B (PKB) Inhibitors</title><date>2009-11-25</date><risdate>2009</risdate><abstract>The invention relates to methods of using thiazole compounds of Formula I and Formula II and compositions thereof for treating diseases mediated by protein kinase B (PKB) such as cancer and other proliferative disorders where the variables have the definitions provided herein.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_ZA200806386B |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Thiazole compounds as protein kinase B (PKB) Inhibitors |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T14%3A21%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WOHLHIETER,%20GEORGE%20E&rft.date=2009-11-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EZA200806386B%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |